Literature DB >> 233036

PGI2 and PGD2 effects on cyclic AMP and human T-cell mitogenesis.

S W Burchiel.   

Abstract

The effects of PGI2, PGD2, and PGF2 alpha on human peripheral blood lymphocytes (HPBL) cyclic AMP levels and their response to a T cell mitogen (PHA) were investigated. It was determined that although PGI2, PGD2, and PGE2 all elevate intracellular levels of cyclic AMP in HPBL, only PGD2 and PGE2 exert potent suppression of PHA-induced lymphocyte proliferation. It is suggested that the instability of PGI2 in aqueous solution is at least partially responsible for its relative inability to maintain elevated levels of cyclic AMP and concomitant suppression of mitogenesis. PGD2 was found to exert an effect very similar to PGE2, both in terms of cyclic AMP elevation and suppression of T cell mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 233036     DOI: 10.1016/0161-4630(79)90073-9

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  4 in total

1.  Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro.

Authors:  S Kuno; R Ueno; O Hayaishi; H Nakashima; S Harada; N Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice.

Authors:  L A Mitchell; F T Lauer; S W Burchiel; J D McDonald
Journal:  Nat Nanotechnol       Date:  2009-06-14       Impact factor: 39.213

3.  Prostaglandin E2 administered via anus causes immunosuppression in male but not female rats: a possible pathogenesis of acquired immune deficiency syndrome in homosexual males.

Authors:  S Kuno; R Ueno; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Attenuation of immune complex nephritis in NZB/WF1 mice by a prostacyclin analogue.

Authors:  Y Utsunomiya; M Ogura; T Kawamura; T Mitarai; N Maruyama; O Sakai
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.